Bilirubin Blood Test: A Leading Driver Behind Rising Incidences Of Liver Diseases Driving Growth In The Bilirubin Blood Test Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Bilirubin Blood Test Industry Market Size Be by 2025?
The market for bilirubin blood tests has seen a robust expansion in recent years, and it is anticipated to rise from $1.37 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. Various factors have contributed to this growth during the historic period, including a higher occurrence of liver disease, improvements in neonatal care, technological innovations, an increase in health consciousness, advancements in healthcare facilities, regulatory endorsements and recommendations, and a boosted acceptance of point-of-care testing.

What's the Long-Term Growth Forecast for the Bilirubin Blood Test Market Size Through 2029?
The market for bilirubin blood tests is predicted to experience substantial growth in the forthcoming years, escalating to a value of $1.96 billion by 2029, with a compound annual growth rate (CAGR) of 7.5%. The projected growth during the forecast period is resultant from factors such as the rising demand for early diagnosis, proliferation of diagnostic laboratories, escalating prevalence of chronic diseases, growth in emerging markets, adoption of advanced analytics, and increased funding for research. Over the forecast period, significant trends to watch include the evolution of non-invasive testing techniques, amalgamation with digital health solutions, advancements in home testing kits, improvement in test precision and speed, strategies toward personalized medicine, innovative smart diagnostic tools, and the creation of compact devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

What Are the Key Growth Drivers Fueling the Bilirubin Blood Test Market Expansion?
The increasing instances of liver ailments are predicted to boost the expansion of the bilirubin blood test market. When it comes to liver diseases, these could range from several factors like infections, excessive alcohol usage or metabolic disorders resulting in compromising the normal functioning of the liver. The surge in liver disease cases is connected to the escalating rates of obesity, over-consumption of alcohol, viral infections, and poor lifestyle decisions, all of which collectively lead to liver malfunction and damage. The level of bilirubin in the body can be markedly influenced by liver disease, and bilirubin blood tests help to diagnose and observe liver performance, offering key details into patients' health while assisting healthcare professionals in handling and effectively treating liver-associated conditions. For example, in April 2024, as per the European Centre for Disease Prevention and Control, a health agency run by the Swedish government, there was a record of 28,855 cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, showing an increase of 78% compared to the 16,187 cases seen in 2021. Moreover, the case tally in 2022, coming in at 28,420, equates to a crude rate of 8.5 instances per 100,000 citizens. Consequently, the swelling number of liver disease occurrences are fuelling the growth of the bilirubin blood test market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Are the Key Trends Driving Bilirubin Blood Test Market Growth?
Leading firms in the bilirubin blood test market are leveraging strategic partnerships to broaden their influence and strengthen their services. A strategic partnership usually involves a cooperative relationship between multiple organizations, where they merge their resources, skills, and endeavours to attain mutual targets. A prime example was in December 2023, when Calmark Sweden AB, a biotechnological medical diagnostic solution company based in Israel, entered into an unique distribution alliance with Techno Orbits in Saudi Arabia for Calmark's neonatal bilirubin test. Techno Orbits is tasked with managing the sale and distribution of the product, capitalizing on its pre-existing network and affiliations, Ministry of Health included. The underlying objective of this partnership is to ease the introduction of Calmark's bilirubin test in the Saudi market, with regulatory approval projected to be acquired within a period of 3 to 6 months.

How Is the Bilirubin Blood Test Market Segmented?
The bilirubin blood test market covered in this report is segmented -

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test
2) By Age Group: Adults, Pediatrics, Infants
3) By Application: Hospital, Clinic, Other Applications

Subsegments:
1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection
2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert's Syndrome Detection, Monitoring For Preliver Conditions
3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Which Companies Are Leading the Charge in Bilirubin Blood Test Market Innovation?
Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Which Regions Are Leading the Global Bilirubin Blood Test Market in Revenue?
North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18522

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.